Megan Becker, PA-C is a psychiatric physician assistant at Relief Mental Health’s Chicago West Loop clinic. She provides medication management and specializes in treating adults 18 and older for a range of mental health concerns, including anxiety, depression, eating disorders, trauma/PTSD, sleep disorders and insomnia, pregnancy and postpartum mental health issues, and women’s issues. Megan is state-licensed and nationally board-certified, bringing a wealth of experience and expertise to her practice.
Megan’s patients receive empathetic care and guidance to navigate mental health challenges in a supportive, non-judgmental environment. They may be coping with ADHD, anxiety, depression, bipolar disorder, trauma, or personality disorders. Megan is dedicated to tailoring individualized treatment plans that empower patients to achieve mental well-being and resilience. Her therapeutic approaches include Motivational Interviewing, Person-Centered Therapy, Trauma-Focused interventions, and Mindfulness-Based techniques. These evidence-based methods foster self-awareness, healing, and long-term growth, ensuring each person feels heard and supported on their journey toward wellness.
Megan earned her Master’s in Physician Assistant Studies from Butler University and has extensive experience working with young adults, adults, and the geriatric population from diverse racial, cultural, and socioeconomic backgrounds. She is deeply committed to helping individuals overcome challenges such as adjustment disorders, complex trauma, and impulse control disorders. Megan provides a safe space for patients to explore their feelings and goals while working together to develop personalized strategies for recovery and wellness.
At Relief Mental Health, Megan also offers SPRAVATO® (esketamine), an FDA-approved treatment for adults with treatment-resistant depression or depressive symptoms associated with suicidal thoughts or actions. Administered as a nasal spray under medical supervision, SPRAVATO® works differently from traditional antidepressants by targeting NMDA receptors in the brain. This innovative therapy offers new hope for patients who have not found relief with other treatments, helping to alleviate symptoms and improve quality of life.
With a steadfast dedication to her patients, Megan combines clinical expertise and compassionate care to guide individuals toward a healthier, more fulfilling life.